DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Growth Science Ventures
Growth Science Ventures
Growth investor · probableHenderson, NVgrowthsci.comSEC exempt reporting adviserfundraising evidence
GS Ventures is changing the way large organizations think about venture capital. Read how our proprietary analytics and data science helps identify future market leaders.
growth or late-stage vehicles only
Importance
6
low
Active deployment
35
elevated
Emerging
56
elevated
Completeness
63
high
Freshness
100
high
Research priority
24
moderate
Identity and regulatory footprint
- Headquarters
- Henderson, NVadviserinfo.sec.gov
- Office address
- 1887 WHITNEY MESA DRIVE, SUITE 7005, Henderson, NV, 89014adviserinfo.sec.gov
- Business phone
- 5037173831adviserinfo.sec.gov
- Website
- http://www.gsventures.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- Mar 26, 2026
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $55.0Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business phone
- 206-923-9003adviserinfo.sec.govpublished by the subject
- business phone
- 5037173831adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- ai, medtech
- Stages
- seed, series a, series b
- Geography
- worldwide
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
2 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Hambrecht Ducera Healthcare Growth Ventures Fund II, LP | Growth fund | unknown | Unknown | $19.7M Mar 22, 2024 | 5 | unknown | unknown |
| Science Ventures Fund IV, L.P. | Fund | unknown | Fundraising | unknown | unknown | $0 of $100M | Feb 10, 2026 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
1 current, 0 departed
Thomas Albert Thurston
PartnerMember · since Oct 1, 2017
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
3 dated events
- Mar 7, 2023Growth Science Ventures first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 7, 2023Hambrecht Ducera Healthcare Growth Ventures Fund II, LP first reported on Form ADV by Growth Science Ventures (Venture Capital Fund), GAV $19,700,000Fund first reported on Form ADVFundsFactHambrecht Ducera Healthcare Growth Ventures Fund II, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 7, 2023Hambrecht Ducera Healthcare Growth Ventures Fund I, LP first reported on Form ADV by Growth Science Ventures (Venture Capital Fund), GAV $35,300,000Fund first reported on Form ADVFundsFactHambrecht Ducera Healthcare Growth Ventures Fund I, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Growth investor (probable, 80%, cls-1)growth or late-stage vehicles only
Evidence
44 observations from 3 sources